GL1X · GenesisL1 explorer

Research workbench

Human ARTD3 (PARP3) - catalytic domain in complex with inhibitor STO1542

Analyse Human ARTD3 (PARP3) - catalytic domain in complex with inhibitor STO1542 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4L7O
Type
protein
Length
354 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Poly [ADP-ribose] polymerase 3
EC
2.4.2.30
UniProt
Q9Y6F1
Ligands
1VD
Pockets
3 · best druggability 0.74

Structure

x-ray diffraction · 1 distinct chain · 37% helix, 23% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APoly [ADP-ribose] polymerase 3 (EC 2.4.2.30)protein35437% helix, 23% strandQ9Y6F1

Ligands and binding sites

  • 1VD · N-{(1S)-1-[4-(1H-imidazol-1-yl)phenyl]ethyl}-3-(4-oxo-3,4-dihydroquinazolin-2-yl)propanamide · ligand · chains A
  • DMS · Dimethyl sulfoxide · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14780.740.83451VD, DMS
2870.340.7420empty
3530.280.7514empty

Compared structures

  • 4L7O · Human artd3 (parp3) - catalytic domain in complex with inhibitor STO1542 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9Y6F1 · AlphaFold monomer V2.0 prediction for protein mono-ADP- ribosyltransferase PARP3 (Q9Y6F1) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.